Drug Approvals

Zilbrysq: FDA-Approved on October 17, 2023, for Treating Generalized Myasthenia Gravis

Zilbrysq: FDA-Approved on October 17, 2023, for Treating Generalized Myasthenia Gravis

What is Zilbrysq prescribed for?   Zilbrysq is prescribed to treat generalized myasthenia gravis in adults who are anti-acetylcholine receptor (AChR) antibody positive. What is the name of the drug and what does it do?  Zilbrysq, pronounced ZIL-brisk, (generic name: zilucoplan) is  for generalized myasthenia gravis (MG) treatment in adults. ...

FDA Approval on February 16, 2023: LAMZEDE Breakthrough for Alpha-Mannosidosis Treatment

FDA Approval on February 16, 2023: LAMZEDE Breakthrough for Alpha-Mannosidosis Treatment

What is LAMZEDE prescribed for?    For the treatment of non-central nervous system manifestations of alpha-mannosidosis in adult and pediatric patients. What is the name of the drug and what does it do?  LAMZEDE (generic name: velmanase alfa-tycv), pronouonced “lam-zed,” is a medicine made from human genes that helps treat the non-brain...

A New Era in Lung Cancer Treatment: FDA Approves Augtyro on November 15, 2023

A New Era in Lung Cancer Treatment: FDA Approves Augtyro on November 15, 2023

What is Augtyro prescribed for?  Augtyro is prescribed for the treatment of adult patients with locally advanced or metastatic ROS1-positive non-small cell lung cancer. What is Augtyro and what does it do? Augtyro, pronounced Aug-TYE-ro, (generic name: repotrectinib) is a newly FDA-approved medication for treating a specific type of lung cancer called...

FDA Approves Izervay for Treating Severe  Age-related Macular Degeneration August 4, 2023

FDA Approves Izervay for Treating Severe  Age-related Macular Degeneration August 4, 2023

What is Izervay prescribed for?   Izervay is prescribed to treat geographic atrophy (GA) secondary to age-related macular degeneration. What is the name of the drug and what does it do? Izervay, pronounced  EYE-ZER-VEY, (generic name: avacincaptad pegol) is a prescription medication approved for the treatment of geographic atrophy (GA), which is a...

New Use for Wegovy Approved by FDA to Reduce Cardiovascular Risk:  March 08, 2024

New Use for Wegovy Approved by FDA to Reduce Cardiovascular Risk:  March 08, 2024

What is Wegovy prescribed for?   Wegovy (generic name: semaglutide), pronounced “weh-Go-veeh,” is an injectable prescription medication for adults with obesity (BMI ≥30) or overweight (excess weight) (BMI ≥27) who also have weight-related medical problems, to help them lose weight and keep it off. What is the name of the drug and what does it do?  The...

Exciting New Drug Approval: WINREVAIR: March 26, 2024

Exciting New Drug Approval: WINREVAIR: March 26, 2024

What is WINREVAIR prescribed for?  WINREVAIR is prescribed to treat adults with pulmonary arterial hypertension. What is the name of the drug and what does it do? WINREVAIR pronounced WIN-reh-vair, (generic name: sotatercept-csrk) is used to treat adults with pulmonary arterial hypertension (PAH), a condition where there is high blood pressure in the arteries...